nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—DRD3—bipolar disorder	0.456	0.591	CbGaD
Metoclopramide—DRD2—bipolar disorder	0.315	0.409	CbGaD
Metoclopramide—DRD3—telencephalic ventricle—bipolar disorder	0.0116	0.183	CbGeAlD
Metoclopramide—CYP11B2—blood plasma—bipolar disorder	0.008	0.126	CbGeAlD
Metoclopramide—HTR4—adrenal cortex—bipolar disorder	0.00721	0.114	CbGeAlD
Metoclopramide—DRD2—telencephalic ventricle—bipolar disorder	0.00492	0.0775	CbGeAlD
Metoclopramide—CYP11B2—adrenal cortex—bipolar disorder	0.00406	0.064	CbGeAlD
Metoclopramide—CYP11B1—adrenal cortex—bipolar disorder	0.00406	0.064	CbGeAlD
Metoclopramide—HTR4—brain—bipolar disorder	0.00323	0.0509	CbGeAlD
Metoclopramide—CYP2D6—urine—bipolar disorder	0.0027	0.0426	CbGeAlD
Metoclopramide—CYP17A1—adrenal cortex—bipolar disorder	0.00248	0.0391	CbGeAlD
Metoclopramide—CYP17A1—thyroid gland—bipolar disorder	0.00173	0.0272	CbGeAlD
Metoclopramide—DRD3—nervous system—bipolar disorder	0.00165	0.026	CbGeAlD
Metoclopramide—CYP17A1—nervous system—bipolar disorder	0.00145	0.0229	CbGeAlD
Metoclopramide—Bromopride—DRD2—bipolar disorder	0.00142	0.19	CrCbGaD
Metoclopramide—CYP2D6—blood plasma—bipolar disorder	0.00141	0.0222	CbGeAlD
Metoclopramide—DRD3—brain—bipolar disorder	0.00126	0.0199	CbGeAlD
Metoclopramide—HTR3A—nervous system—bipolar disorder	0.00114	0.018	CbGeAlD
Metoclopramide—CYP17A1—brain—bipolar disorder	0.00111	0.0175	CbGeAlD
Metoclopramide—Amisulpride—DRD3—bipolar disorder	0.00108	0.144	CrCbGaD
Metoclopramide—Sunitinib—NTRK1—bipolar disorder	0.000957	0.128	CrCbGaD
Metoclopramide—HTR3A—brain—bipolar disorder	0.000872	0.0137	CbGeAlD
Metoclopramide—CHRM1—nervous system—bipolar disorder	0.000866	0.0137	CbGeAlD
Metoclopramide—Amisulpride—DRD2—bipolar disorder	0.000746	0.0996	CrCbGaD
Metoclopramide—Chloroprocaine—SLC6A3—bipolar disorder	0.000707	0.0944	CrCbGaD
Metoclopramide—DRD2—nervous system—bipolar disorder	0.000698	0.011	CbGeAlD
Metoclopramide—Procaine—SLC6A3—bipolar disorder	0.000674	0.09	CrCbGaD
Metoclopramide—CHRM1—brain—bipolar disorder	0.000662	0.0104	CbGeAlD
Metoclopramide—DRD2—cerebellum—bipolar disorder	0.000657	0.0103	CbGeAlD
Metoclopramide—Amisulpride—HTR2A—bipolar disorder	0.000576	0.077	CrCbGaD
Metoclopramide—Cisapride—HTR2C—bipolar disorder	0.000542	0.0724	CrCbGaD
Metoclopramide—DRD2—brain—bipolar disorder	0.000533	0.0084	CbGeAlD
Metoclopramide—Cisapride—DRD2—bipolar disorder	0.000447	0.0597	CrCbGaD
Metoclopramide—CYP2D6—nervous system—bipolar disorder	0.000419	0.00661	CbGeAlD
Metoclopramide—CYP2D6—cerebellum—bipolar disorder	0.000395	0.00622	CbGeAlD
Metoclopramide—Cisapride—HTR2A—bipolar disorder	0.000345	0.0461	CrCbGaD
Metoclopramide—CYP2D6—brain—bipolar disorder	0.00032	0.00505	CbGeAlD
Metoclopramide—HTR4—Signaling Pathways—ADCY2—bipolar disorder	5.35e-05	0.000338	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TCF7L2—bipolar disorder	5.34e-05	0.000337	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CACNA1C—bipolar disorder	5.33e-05	0.000337	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—DRD2—bipolar disorder	5.3e-05	0.000335	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADM—bipolar disorder	5.29e-05	0.000334	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—DRD3—bipolar disorder	5.29e-05	0.000334	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	5.24e-05	0.000331	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—DRD4—bipolar disorder	5.24e-05	0.000331	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—COMT—bipolar disorder	5.23e-05	0.00033	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3C2A—bipolar disorder	5.2e-05	0.000328	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—MAOA—bipolar disorder	5.19e-05	0.000328	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—GSK3B—bipolar disorder	5.15e-05	0.000325	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	5.15e-05	0.000325	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PDE4B—bipolar disorder	5.15e-05	0.000325	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TSHB—bipolar disorder	5.15e-05	0.000325	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TACR1—bipolar disorder	5.15e-05	0.000325	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	5.13e-05	0.000324	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—DRD4—bipolar disorder	5.13e-05	0.000324	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.13e-05	0.000324	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD5—bipolar disorder	5.08e-05	0.000321	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—GSK3B—bipolar disorder	5.04e-05	0.000319	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TRPC3—bipolar disorder	5.03e-05	0.000318	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—POMC—bipolar disorder	5.02e-05	0.000317	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CACNA1C—bipolar disorder	4.99e-05	0.000315	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RGS4—bipolar disorder	4.98e-05	0.000315	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD5—bipolar disorder	4.97e-05	0.000314	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RGS4—bipolar disorder	4.88e-05	0.000308	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3C2A—bipolar disorder	4.86e-05	0.000307	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADM—bipolar disorder	4.8e-05	0.000303	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NTRK1—bipolar disorder	4.8e-05	0.000303	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.8e-05	0.000303	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ADCY2—bipolar disorder	4.79e-05	0.000302	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—DRD2—bipolar disorder	4.78e-05	0.000302	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.69e-05	0.000296	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PDE4B—bipolar disorder	4.68e-05	0.000295	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TSHB—bipolar disorder	4.68e-05	0.000295	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TACR1—bipolar disorder	4.68e-05	0.000295	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—S100B—bipolar disorder	4.66e-05	0.000294	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—SNAP25—bipolar disorder	4.66e-05	0.000294	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKR1C4—bipolar disorder	4.66e-05	0.000294	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—POMC—bipolar disorder	4.51e-05	0.000285	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	4.49e-05	0.000284	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—IMPA2—bipolar disorder	4.47e-05	0.000282	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2A—bipolar disorder	4.47e-05	0.000282	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	4.4e-05	0.000278	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—SNAP25—bipolar disorder	4.36e-05	0.000275	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DGKH—bipolar disorder	4.29e-05	0.000271	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR1A—bipolar disorder	4.26e-05	0.000269	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TRPC3—bipolar disorder	4.24e-05	0.000268	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TAC1—bipolar disorder	4.2e-05	0.000265	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TRPC3—bipolar disorder	4.15e-05	0.000262	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ADCY2—bipolar disorder	4.13e-05	0.000261	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2C—bipolar disorder	4.12e-05	0.00026	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD1—bipolar disorder	4.12e-05	0.00026	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NRG1—bipolar disorder	4.12e-05	0.00026	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—COMT—bipolar disorder	4.1e-05	0.000259	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MAOA—bipolar disorder	4.07e-05	0.000257	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADM—bipolar disorder	4.04e-05	0.000255	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADM—bipolar disorder	3.96e-05	0.00025	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TSHB—bipolar disorder	3.94e-05	0.000249	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PDE4B—bipolar disorder	3.94e-05	0.000249	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TACR1—bipolar disorder	3.94e-05	0.000249	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD5—bipolar disorder	3.92e-05	0.000248	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR1A—bipolar disorder	3.87e-05	0.000245	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD4—bipolar disorder	3.87e-05	0.000244	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ADCY2—bipolar disorder	3.86e-05	0.000244	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PDE4B—bipolar disorder	3.86e-05	0.000244	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TSHB—bipolar disorder	3.86e-05	0.000244	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TACR1—bipolar disorder	3.86e-05	0.000244	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TRPC3—bipolar disorder	3.85e-05	0.000243	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RGS4—bipolar disorder	3.85e-05	0.000243	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TAC1—bipolar disorder	3.81e-05	0.000241	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TRPC3—bipolar disorder	3.77e-05	0.000238	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD1—bipolar disorder	3.74e-05	0.000236	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2C—bipolar disorder	3.74e-05	0.000236	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2A—bipolar disorder	3.71e-05	0.000234	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADM—bipolar disorder	3.67e-05	0.000232	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADCY2—bipolar disorder	3.64e-05	0.00023	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD2—bipolar disorder	3.61e-05	0.000228	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADM—bipolar disorder	3.59e-05	0.000227	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.59e-05	0.000227	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TSHB—bipolar disorder	3.58e-05	0.000226	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PDE4B—bipolar disorder	3.58e-05	0.000226	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TACR1—bipolar disorder	3.58e-05	0.000226	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—POMC—bipolar disorder	3.57e-05	0.000225	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKR1C4—bipolar disorder	3.57e-05	0.000225	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—COMT—bipolar disorder	3.53e-05	0.000223	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD4—bipolar disorder	3.52e-05	0.000222	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.51e-05	0.000222	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MAOA—bipolar disorder	3.51e-05	0.000222	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PDE4B—bipolar disorder	3.5e-05	0.000221	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TSHB—bipolar disorder	3.5e-05	0.000221	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TACR1—bipolar disorder	3.5e-05	0.000221	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKR1C4—bipolar disorder	3.49e-05	0.00022	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2A—bipolar disorder	3.42e-05	0.000216	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—POMC—bipolar disorder	3.38e-05	0.000213	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	3.35e-05	0.000211	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MTHFR—bipolar disorder	3.31e-05	0.000209	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADCY2—bipolar disorder	3.31e-05	0.000209	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—COMT—bipolar disorder	3.3e-05	0.000209	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MAOA—bipolar disorder	3.28e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DGKH—bipolar disorder	3.28e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD2—bipolar disorder	3.28e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR1A—bipolar disorder	3.26e-05	0.000206	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TAC1—bipolar disorder	3.21e-05	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DGKH—bipolar disorder	3.21e-05	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	3.19e-05	0.000202	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD1—bipolar disorder	3.15e-05	0.000199	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2C—bipolar disorder	3.15e-05	0.000199	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	3.14e-05	0.000199	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	3.08e-05	0.000195	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	3.08e-05	0.000195	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD3—bipolar disorder	3.05e-05	0.000193	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—IMPA1—bipolar disorder	3.02e-05	0.000191	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD5—bipolar disorder	3e-05	0.00019	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GSK3B—bipolar disorder	2.99e-05	0.000189	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	2.99e-05	0.000189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TRPC3—bipolar disorder	2.97e-05	0.000188	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—POMC—bipolar disorder	2.96e-05	0.000187	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1A—bipolar disorder	2.96e-05	0.000187	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD4—bipolar disorder	2.96e-05	0.000187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—INS—bipolar disorder	2.95e-05	0.000186	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RGS4—bipolar disorder	2.94e-05	0.000186	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD5—bipolar disorder	2.94e-05	0.000185	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TAC1—bipolar disorder	2.92e-05	0.000184	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	2.9e-05	0.000183	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	2.9e-05	0.000183	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RGS4—bipolar disorder	2.88e-05	0.000182	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2C—bipolar disorder	2.86e-05	0.000181	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD1—bipolar disorder	2.86e-05	0.000181	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MTHFR—bipolar disorder	2.86e-05	0.00018	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	2.86e-05	0.00018	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADM—bipolar disorder	2.84e-05	0.000179	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	2.8e-05	0.000177	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	2.8e-05	0.000177	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADCY2—bipolar disorder	2.79e-05	0.000176	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD3—bipolar disorder	2.77e-05	0.000175	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TSHB—bipolar disorder	2.76e-05	0.000174	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PDE4B—bipolar disorder	2.76e-05	0.000174	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TACR1—bipolar disorder	2.76e-05	0.000174	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—POMC—bipolar disorder	2.73e-05	0.000173	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	2.73e-05	0.000172	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	2.71e-05	0.000171	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	2.7e-05	0.000171	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD4—bipolar disorder	2.69e-05	0.00017	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—POMC—bipolar disorder	2.67e-05	0.000169	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MTHFR—bipolar disorder	2.67e-05	0.000169	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—POMC—bipolar disorder	2.65e-05	0.000167	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—INS—bipolar disorder	2.64e-05	0.000166	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	2.63e-05	0.000166	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NDUFV2—bipolar disorder	2.57e-05	0.000162	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	2.53e-05	0.00016	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—bipolar disorder	2.53e-05	0.00016	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKR1C4—bipolar disorder	2.49e-05	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	2.48e-05	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	2.45e-05	0.000155	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—bipolar disorder	2.29e-05	0.000145	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1A—bipolar disorder	2.29e-05	0.000144	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—POMC—bipolar disorder	2.28e-05	0.000144	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TRPC3—bipolar disorder	2.27e-05	0.000144	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—INS—bipolar disorder	2.27e-05	0.000143	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TAC1—bipolar disorder	2.25e-05	0.000142	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NR1D1—bipolar disorder	2.23e-05	0.000141	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	2.23e-05	0.000141	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD1—bipolar disorder	2.21e-05	0.00014	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2C—bipolar disorder	2.21e-05	0.00014	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADM—bipolar disorder	2.17e-05	0.000137	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK2—bipolar disorder	2.15e-05	0.000136	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NCAN—bipolar disorder	2.14e-05	0.000135	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—POMC—bipolar disorder	2.14e-05	0.000135	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GSK3A—bipolar disorder	2.13e-05	0.000135	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—INS—bipolar disorder	2.12e-05	0.000134	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADM—bipolar disorder	2.12e-05	0.000134	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PDE4B—bipolar disorder	2.11e-05	0.000134	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TSHB—bipolar disorder	2.11e-05	0.000134	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TACR1—bipolar disorder	2.11e-05	0.000134	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.09e-05	0.000132	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD4—bipolar disorder	2.08e-05	0.000131	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TACR1—bipolar disorder	2.07e-05	0.000131	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TSHB—bipolar disorder	2.07e-05	0.000131	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	2.07e-05	0.000131	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—POMC—bipolar disorder	2.02e-05	0.000127	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADCY2—bipolar disorder	1.96e-05	0.000123	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TCF7L2—bipolar disorder	1.95e-05	0.000123	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD2—bipolar disorder	1.93e-05	0.000122	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	1.93e-05	0.000122	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	1.89e-05	0.000119	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—POMC—bipolar disorder	1.83e-05	0.000116	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.76e-05	0.000111	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK1—bipolar disorder	1.75e-05	0.000111	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.75e-05	0.000111	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TAC1—bipolar disorder	1.72e-05	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	1.72e-05	0.000108	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	1.71e-05	0.000108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—S100B—bipolar disorder	1.7e-05	0.000108	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD1—bipolar disorder	1.69e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2C—bipolar disorder	1.69e-05	0.000107	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TAC1—bipolar disorder	1.69e-05	0.000107	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD1—bipolar disorder	1.65e-05	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	1.65e-05	0.000104	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK2—bipolar disorder	1.64e-05	0.000104	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD3—bipolar disorder	1.64e-05	0.000103	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GSK3A—bipolar disorder	1.63e-05	0.000103	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	1.61e-05	0.000102	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD3—bipolar disorder	1.6e-05	0.000101	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	1.6e-05	0.000101	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD4—bipolar disorder	1.59e-05	0.0001	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD4—bipolar disorder	1.56e-05	9.82e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—POMC—bipolar disorder	1.54e-05	9.75e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.51e-05	9.56e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	1.51e-05	9.54e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NRG1—bipolar disorder	1.5e-05	9.49e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADCY2—bipolar disorder	1.5e-05	9.45e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.49e-05	9.41e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TPH2—bipolar disorder	1.48e-05	9.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TSHB—bipolar disorder	1.48e-05	9.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.48e-05	9.31e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	1.46e-05	9.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	1.46e-05	9.21e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DPYD—bipolar disorder	1.45e-05	9.16e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD2—bipolar disorder	1.45e-05	9.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—bipolar disorder	1.4e-05	8.85e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—bipolar disorder	1.37e-05	8.66e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—bipolar disorder	1.36e-05	8.56e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.35e-05	8.52e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK1—bipolar disorder	1.34e-05	8.47e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.31e-05	8.3e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	1.31e-05	8.28e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—S100B—bipolar disorder	1.3e-05	8.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—S100B—bipolar disorder	1.28e-05	8.05e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.18e-05	7.45e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NRG1—bipolar disorder	1.15e-05	7.26e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NRG1—bipolar disorder	1.13e-05	7.11e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GSK3B—bipolar disorder	1.09e-05	6.89e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—bipolar disorder	1.08e-05	6.83e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—INS—bipolar disorder	1.08e-05	6.8e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.04e-05	6.59e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—bipolar disorder	1.04e-05	6.55e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	1.01e-05	6.41e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—COMT—bipolar disorder	8.94e-06	5.64e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOA—bipolar disorder	8.87e-06	5.6e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GSK3B—bipolar disorder	8.35e-06	5.27e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—bipolar disorder	8.28e-06	5.23e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—INS—bipolar disorder	8.24e-06	5.2e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	8.17e-06	5.16e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—bipolar disorder	8.11e-06	5.12e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—INS—bipolar disorder	8.06e-06	5.09e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—bipolar disorder	7.22e-06	4.56e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—bipolar disorder	5.78e-06	3.65e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—INS—bipolar disorder	5.75e-06	3.63e-05	CbGpPWpGaD
